144 related articles for article (PubMed ID: 27295491)
21. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.
Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095
[TBL] [Abstract][Full Text] [Related]
22. Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus.
Ushirobira CY; Afiune LAF; Pereira MN; Cunha-Filho M; Gelfuso GM; Gratieri T
Int J Biol Macromol; 2020 May; 151():56-61. PubMed ID: 32068053
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
Garcia-Fuentes M; Prego C; Torres D; Alonso MJ
Eur J Pharm Sci; 2005 May; 25(1):133-43. PubMed ID: 15854809
[TBL] [Abstract][Full Text] [Related]
25. RES-loaded pegylated CS NPs: for efficient ocular delivery.
Pandian S; Jeevanesan V; Ponnusamy C; Natesan S
IET Nanobiotechnol; 2017 Feb; 11(1):32-39. PubMed ID: 28476958
[TBL] [Abstract][Full Text] [Related]
26. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
27. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
Patil GB; Surana SJ
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
[TBL] [Abstract][Full Text] [Related]
28. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
29. Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats.
Benvegnú DM; Barcelos RC; Boufleur N; Reckziegel P; Pase CS; Ourique AF; Beck RC; Bürger ME
Eur J Pharm Biopharm; 2011 Feb; 77(2):332-6. PubMed ID: 21168486
[TBL] [Abstract][Full Text] [Related]
30. Effect of polyethylene glycol coatings on uptake of indocyanine green loaded nanocapsules by human spleen macrophages in vitro.
Bahmani B; Gupta S; Upadhyayula S; Vullev VI; Anvari B
J Biomed Opt; 2011 May; 16(5):051303. PubMed ID: 21639563
[TBL] [Abstract][Full Text] [Related]
31. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
32. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
33. Haloperidol-loaded polysorbate-coated polymeric nanocapsules decrease its adverse motor side effects and oxidative stress markers in rats.
Benvegnú DM; Barcelos RC; Boufleur N; Pase CS; Reckziegel P; Flores FC; Ourique AF; Nora MD; da Silva Cde B; Beck RC; Bürger ME
Neurochem Int; 2012 Oct; 61(5):623-31. PubMed ID: 22750274
[TBL] [Abstract][Full Text] [Related]
34. Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules.
Groo AC; Mircheva K; Bejaud J; Ailhas C; Panaiotov I; Saulnier P; Ivanova T; Lagarce F
Pharm Res; 2014 Jul; 31(7):1753-65. PubMed ID: 24469905
[TBL] [Abstract][Full Text] [Related]
35. Transmucosal macromolecular drug delivery.
Prego C; García M; Torres D; Alonso MJ
J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
[TBL] [Abstract][Full Text] [Related]
36. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
37. PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release.
Jiang G; Sun J; Ding F
J Biomater Sci Polym Ed; 2014; 25(3):241-56. PubMed ID: 24160458
[TBL] [Abstract][Full Text] [Related]
38. PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties.
Hervella P; Alonso-Sande M; Ledo F; Lucero ML; Alonso MJ; Garcia-Fuentes M
Curr Top Med Chem; 2014; 14(9):1115-23. PubMed ID: 24678710
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol-loaded core-shell nanostructured delivery systems: Cyclodextrin-based metal-organic nanocapsules prepared by ionic gelation.
Qiu C; Julian McClements D; Jin Z; Qin Y; Hu Y; Xu X; Wang J
Food Chem; 2020 Jul; 317():126328. PubMed ID: 32087520
[TBL] [Abstract][Full Text] [Related]
40. Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations.
Real D; Hoffmann S; Leonardi D; Salomon C; Goycoolea FM
PLoS One; 2018; 13(12):e0207625. PubMed ID: 30540811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
